Michelle Renee Griffin, Director at Adaptive Biotechnologies Corp (ADPT), sold 52,084 shares at $20.18 ($1.1M) on 2026-06-25, disclosed to the SEC on 2026-06-29.
Scheduled sale ($1.1M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ADPT | SELL | 2025-03-17 | $522K | — | Filing → |
| ADPT | SELL | 2025-03-06 | $249K | — | Filing → |
| ADPT | SELL | 2023-03-29 | $20K | — | Filing → |